Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?

Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Elisabeth Maillart, Caroline Papeix, Catherine Lubetzki, Thomas Roux, Valérie Pourcher, Céline Louapre
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research